Conscious Sedation Clinical Trial
Official title:
Magnesium Sulphate Versus Fentanyl as Adjuvants to Propofol Xylocaine Combination for Conscious Sedation During Chronic Subdural Haematoma Surgery. Comparative Study
The investigators hypothesize that magnesium sulphate owing to its analgesic and sedative properties is not inferior to fentanyl in providing conscious sedation as adjuvants to propofol and local injection of lidocaine in patients undergoing surgery for evacuation of subdural haematoma. Consequently, the investigators are testing this hypothesis by comparing the sedative and analgesic effects of magnesium sulphate versus fentanyl as adjuvants to propofol lidocaine admixture for conscious sedation in patients undergoing burr hole surgery for evacuation of subdural haematoma.
Following institutional ethical committee approval, 34 patients undergoing burr-hole surgery
for chronic subdural hemorrhage were included in this prospective, randomized, double-blind
study.
Written informed consent were obtained from all subjects before enrollment in the study.
During the preanesthetic checkup,the operative procedure and anesthetic techniques were
explained to all patients.
Upon arrival to operating theater, standard monitoring were applied to all patients and
bispectral index was applied before starting the drug infusions and was used for maintenance
of sedation during operation.
Subjects were randomized into 2 groups. Magnesium (M) group received Magnesium sulphate
50mg/kg IV over 15 minutes Followed by continuous infusion at 15 mg/kg/h Fentanyl (F) group
received fentanyl 1 μg /kg IV bolus over 15 minutes Followed by continuous infusion starting
at 0.5 μg /kg/h Loading and infusion doses of magnesium sulphate and loading doses of
fentanyl were chosen from previous studies.
In both groups fentanyl and magnesium sulphate were accompanied by IV propofol at a dose of
50- 150 μg /kg/min bolus over 10 minutes to achieve target sedation level, that is, Ramsay
sedation scale (RSS) 3, if RSS afterwards does not reach 3, a supplementary bolus dose of 0.2
mg/kg propofol were given to the patients, followed by ( 20-40 μg /kg/ min) to maintain
Intraoperative level of sedation by bispectral index (BIS ) reading by 60-80 After achieving
predefined target sedation level (RSS of 3), surgeons infiltrated the sites of the burrholes
with 20 mL of a local anesthetic solution containing 10 mL of 0.5% bupivacaine and 10 mL of
2% lidocaine with adrenaline infiltrated locally at least 5 minutes before surgical incision.
After burr-hole craniotomy followed by the hematoma evacuation is accomplished, the Infusion
of sedatives were discontinued just after placement of the final skin suture.
Intraoperative patient's movement is defined as those likely to interfere with surgical
procedure such as bending of hand and/or leg and movement of head were recorded. The first
intervention is to attempt patient reassurance for 30 seconds. If movement continues then the
bolus dose of propofol of 0.5 mg/kg was given and infusion dose was increased in the
previously described manner till the maximum dose to regain BIS sedation score between 60-80.
If the patient starts to move again the same sequence was repeated. Induction of general
anesthesia was deemed the final intervention in case satisfactory condition was not achieved
within the rescue propofol.
All patients were transferred to the post-anesthesia care unit (PACU) after surgery.
The data collected are:
1. Total amount of Propofol consumption.
2. Total number of patient movements
3. The intraoperative and postoperative hemodynamic data
4. VAS (Visual analogue scale for pain) score
5. Time to first rescue analgesic
6. Adverse events
7. Surgeon satisfaction score was recorded.
Statistical analysis:
Data was analyzed using SPSS © Statistics version 23 (IBM© Corp., Armonk, NY, USA).
Chi-square test (Fisher's exact test) was used to examine the relation between qualitative
variables. For quantitative data, comparison between the two groups was done using
independent sample t-test or Mann-Whitney test as appropriate. All tests were two-tailed. A
p-value < 0.05 was considered significant.
Sample Size calculation:
A previous study reported that pre-procedure magnesium sulphate reduced the total propofol
requirements to 130±19.09 mg compared to 172.8±29.09 mg with pre-procedure fentanyl. Based on
these results, a sample size of 15 cases in each group was satisfactory to elicit the
difference at an alpha level of 0.05 and a power of the test of 95%. The sample size was
increased to 17 per group to compensate for possible dropouts.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT02573818 -
Sedasys Post Approval Study Users Response to System Alarms
|
N/A | |
Recruiting |
NCT01100554 -
Upper Airway Collapsibility Evaluation in Different Sedative Levels by Sleep Endoscopy
|
N/A | |
Terminated |
NCT00226785 -
Dexmedetomidine for Continuous Sedation
|
Phase 3 | |
Completed |
NCT02518919 -
Procedural Sedation And Analgesia in Children in the Emergency Department: The Role of Adjunct Therapies
|
N/A | |
Enrolling by invitation |
NCT04172415 -
Current Procedural Sedation Practices in a Canadian Community Emergency Department
|
||
Completed |
NCT01020643 -
Closed-loop Sedation of Propofol for Patients Undergoing Spinal Anesthesia
|
Phase 4 | |
Completed |
NCT00318955 -
Post-Marketing Clinical Study to Assess Efficacy and Safety of Dexmedetomidine in Post-Operative Patients
|
Phase 4 | |
Completed |
NCT04621526 -
Monitored Anesthesia Care: Dexmedetomidine-Ketamine Versus Dexmedetomidine- Propofol For Chronic Subdural Hematoma
|
Phase 1/Phase 2 | |
Completed |
NCT03085563 -
A Comparison of Intranasal Midazolam and Nitrous Oxide (N2O) Minimal Sedation for Minor Procedures in a Pediatric Emergency Department
|
Phase 4 | |
Completed |
NCT01873612 -
Acute Ventilatory Response to Hypoxia During Sedation With Dexmedetomidine Compared to Propofol in Healthy Male Volunteers
|
Phase 4 | |
Not yet recruiting |
NCT03466242 -
IN Dexmedetomidine for Procedural Sedation in Pediatric Closed Reductions for Distal Forearm Fractures
|
Early Phase 1 | |
Completed |
NCT02679781 -
Nasal Versus Oral Midazolam Sedation in Routine Pediatric Dental Care
|
N/A | |
Completed |
NCT03885427 -
Analgo-Sedative Effects Of Oral, Or Nebulized Ketamine In Pre-schoolers Undergoing Elective Surgery.
|
Early Phase 1 | |
Completed |
NCT00452426 -
Safety and Effectiveness of a Computer-Assisted Personalized Sedation (CAPS) Device for Propofol Delivery During Endoscopy
|
Phase 3 | |
Completed |
NCT00261599 -
An Effectiveness and Safety Study of AQUAVAN® Injection (Fospropofol Disodium) for Sedation During Colonoscopy
|
Phase 3 | |
Completed |
NCT00641563 -
Effects of Two Different Sedation Regimes on Auditory Evoked Potentials and Electroencephalogram (EEG)
|
N/A | |
Active, not recruiting |
NCT01118884 -
Effects of Oral Midazolam in Comparison Promethazine With Nitrous Oxide for Uncooperative Children
|
Phase 3 | |
Terminated |
NCT00809380 -
Parental Presence During Fracture Reduction in Children at the Emergency Department; A Randomized Controlled Trial
|
N/A | |
Completed |
NCT03886454 -
Incidence and Nature of Respiratory Impairment in Consecutive Patients Undergoing Bronchoscopy Under Conscious Sedation: A Pilot Study
|
||
Completed |
NCT03925779 -
Conscious Sedation for Outpatient Colonoscopy
|
Phase 2 |